Dr. Irene Ghobrial discussed the role social media plays in healthcare and how a Facebook and Twitter post help recruit 200 patients for a clinical trial.
Dr. Jonathan Marron led a study that found it's better for
doctors to be open with parents about their child's cancer prognosis, even if
the news is bad.
Dr. Lawrence Shulman discussed his work in both Rwanda and
Haiti, by providing access to life-saving advances in cancer treatment.
Tom Brokaw discussed his life after being diagnosed with multiple myeloma and cites Dr. Ken Anderson for being both a respected clinician and friend.
Dipanjan Chowdhury, PhD, led a study showing a new blood test that could quickly reveal the severity of radiation injury.
Dr. Harold Burstein commented on the increase in women
opting to undergo preventive bilateral mastectomies.
Dr. Pasi Jänne led a study that showed a drug shrank lung tumors in 61 percent of patients whose cancers had developed the T790-M resistance mutation. He also commented on personalized medicine for cancer patients.
Tags: LungCancer, TargetedTherapy
Dr. Philip Kantoff and Dr. Lauren Harshman led a study that found hormone-sensitive prostate cancer patients who started on cholesterol-lowering statin drugs at initiation of androgen-deprivation therapy experienced a longer time to disease progression.
Fifty-three Dana-Farber nurses were recognized by patients
in the Boston Globe as part of the annual "Salute to Nurses"
supplement in celebration of National Nurses Week.
Dr. Pasi Janne led a study showing a new targeted drug as a promising treatment for advanced lung cancers.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: